Category: Pharmaceuticals
Pharmaceuticals market research reports by Euromonitor International
-
Menstrual Care in Tunisia
The menstrual care market in Tunisia recorded positive value growth in 2024, whilst volume growth was marginal. Value growth was driven by inflation and price increases in the year for most menstrual care products due to the rising cost of imported raw materials, transport and distribution. Volume d ... Read More
-
Menstrual Care in Mexico
Menstrual care showed solid growth in Mexico in current value terms in 2024. A low retail volume increase was seen, due to the rising female population aged 12-54, while price rises also contributed to growth. While all categories experienced current value growth, the magnitude varied by product typ ... Read More
-
Rx/Reimbursement Adult Incontinence in Switzerland
Value sales of Rx/reimbursement adult incontinence products rose in 2024. The increase was driven by a growing elderly population requiring long-term care and more consistent support in managing incontinence. In the context of economic uncertainty, many consumers turned to the healthcare system to o ... Read More
-
Tissue and Hygiene in North Macedonia
Tissue and hygiene continued to perform stably in North Macedonia in 2024, with most categories achieving solid RSP value growth rates, which were further boosted by rising prices and the lingering effects of inflation, now stabilising. Most major tissue and hygiene categories have matured. Given th ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovenia
In 2024, Rx/Reimbursement adult incontinence in Slovenia posted moderate volume growth and a healthy, if slower than in 2023, increase in current value sales, supported by residual inflationary pressure on prices. As in retail, Rx/Reimbursement adult incontinence’s performance benefited from the age ... Read More
-
Menstrual Care in Australia
Value sales of menstrual care in Australia continued to rise in 2024, as efforts to raise awareness and destigmatize menstruation continued to gain traction, promoting a more inclusive and open society. This is helping to raise awareness of menstruation, which impacts many aspects of life, from part ... Read More
-
Rx/Reimbursement Adult Incontinence in Australia
While demand for rx/reimbursement adult incontinence in Australia continued to steadily rise in 2024, value growth was much higher. By increasing awareness and education among healthcare professionals, particularly in general practice settings, more individuals experiencing incontinence are being id ... Read More
-
The Future of Inhalation
Inhalation - one of the most common modes of consumption globally - is undergoing a rapid transformation. This report assesses the significant risks for those companies who fail to address that change and the huge opportunities for those who can leverage science, technology and new substance frontie ... Read More
-
Rx/Reimbursement Adult Incontinence in Kazakhstan
Rx/reimbursement adult incontinence in Kazakhstan continued to develop positively in 2024, with volume and current value growth rates improving from 2023. As was the case at the retail level, expansion was primarily driven by the fact that the incidence of incontinence problems in the country is inc ... Read More
-
Rx/Reimbursement Adult Incontinence in Turkey
Sales of Rx/reimbursement adult incontinence saw strong value growth in Turkey in 2024, with volume growth notably lower. This aligns with the cross-category trend of value being more strongly supported by high prices. Whilst retail adult incontinence saw stronger value growth in 2024, compared to R ... Read More
-
Menstrual Care in Uruguay
Menstrual care registered both healthy current value and volume growth in in Uruguay 2024. An improving economy, as well as a significant drop in cross-border shopping into Argentina (due to the appreciation of the Argentine peso), supported the positive performance. Euromonitor International's Mens ... Read More
-
Menstrual Care in Uzbekistan
The rate of growth in retail current value sales of menstrual care slowed significantly but remained robust in 2024. Growth in retail volume sales continued to slow but remained moderate, supported by a steadily rising population of women aged 12-54 years and increased consumer education, especially ... Read More
-
Rx/Reimbursement Adult Incontinence in Serbia
Rx/reimbursement adult incontinence registered healthy current value and volume growth in Serbia in 2024, with an ageing population supporting growth. In addition, with consumer purchasing power under pressure, more users have sought medical prescriptions to help with the cost of adult incontinence. ... Read More
-
Tissue and Hygiene in Bosnia and Herzegovina
Value sales of tissue and hygiene in Bosnia and Herzegovina continued to benefit from the lingering effects of inflation in 2024, which translated into significant product price increases. Whilst inflation slowed in the year, disposable incomes remained chronically low, limiting consumers’ ability t ... Read More
-
Rx/Reimbursement Adult Incontinence in Belgium
Value sales of prescription (RX) and reimbursement adult incontinence products increased in 2024, driven by several key factors. Firstly, Belgium's aging population continued to create consistent demand for these products. Additionally, the rising need for reimbursement for adult incontinence was ex ... Read More
-
Rx/Reimbursement Adult Incontinence in Spain
In 2024, reimbursement adult incontinence saw significant sales growth in Spain. The Spanish healthcare system has adopted a clear strategy by prioritising reimbursement for products specifically designed to manage severe incontinence. This framework reflects not only a commitment to improving patie ... Read More
-
Menstrual Care in Ukraine
Sales of menstrual care declined in current value and retail volume terms in 2024. Value sales declined at a slower rate than in volume terms but this was due to price increases linked to high inflation and the rising cost of logistics. Meanwhile, volume sales continued to be impacted by the fact th ... Read More
-
Rx/Reimbursement Adult Incontinence in Sweden
RX/reimbursement adult incontinence saw steady growth in value and volume terms in 2024. Value growth was primarily driven by two key factors: Sweden’s ageing population and the rising prevalence of obesity and type 2 diabetes. A strong correlation exists between age, underlying health conditions an ... Read More
-
Rx/Reimbursement Adult Incontinence in Poland
In 2024, Rx/reimbursement adult incontinence in Poland continued to post healthy retail volume and current value growth, albeit slower than in 2023 and other years of the review period. As in the retail sphere, demand increased alongside a growing number of consumers in older cohorts, who are more l ... Read More
-
Rx/Reimbursement Adult Incontinence in Slovakia
The landscape of Rx/reimbursement adult incontinence in Slovakia underwent notable changes in 2024 due to regulatory adjustments. From April 2024, new legislation was introduced to refine the prescription process, mandating that doctors indicate the specific level of incontinence on a designated vou ... Read More
-
Rx/Reimbursement Adult Incontinence in Hungary
Current value sales growth of Rx/reimbursement adult incontinence products in Hungary in 2024 was significantly higher compared to retail adult incontinence products. as local consumers could be reimbursed by up to 80% by insurance companies. Doctors determine the appropriate payment group for each ... Read More
-
Rx/Reimbursement Adult Incontinence in Norway
Value sales of RX/reimbursement adult incontinence increased in 2024, driven by an ageing population and a rising obesity rate. The natural expansion of the potential user base contributed to steady demand, while growing health consciousness and hygiene awareness further encouraged individuals to se ... Read More
-
Rx/Reimbursement Adult Incontinence in the Czech Republic
Rx/reimbursement adult incontinence saw volume and value growth in the Czech Republic in 2024. The growth of the category is being fuelled not just by the ageing population but also by more information about Rx rights and reimbursements via magazines and pharmacies. Since 1 January 2024, the VAT rat ... Read More
-
Rx/Reimbursement Adult Incontinence in Denmark
Value sales of RX/reimbursement adult incontinence grew in 2024 in Denmark, supported by the ageing population. It is estimated that around 80% of reimbursement recipients are aged 65 and older, a group that is expanding as life expectancy increases. The ageing population, coupled with rising obesit ... Read More
-
Rx/Reimbursement Adult Incontinence in the Netherlands
Value sales of RX/reimbursement adult incontinence increased modestly in 2024, but negative volume growth continued to exert downward pressure on overall performance. Many consumers opted to purchase incontinence products through retail channels or e-commerce platforms rather than rely on reimbursed ... Read More
Research Assistance
